v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (906,718) $ (18,509,671)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization – film assets 231,917 645,069
Amortization – loan origination fees and debt discounts 4,932 (19,504)
Loss on change in fair value of convertible notes 121,165 82,180
Gain on change in fair value of warrant liabilities (39,243) (91,383)
Depreciation – property and equipment 25,568 135,667
Impairment of film assets 165,987 415,719
Gain on remeasurement of previously held equity interest (7,857)
Gain on lease termination (1,799)
Stock-based compensation expense 101,130 280,888
Deferred taxes, net 10,808,885
Changes in assets and liabilities, net of business acquisitions:    
Accounts receivable 3,182,594 (7,825,905)
Accounts receivable – related party 3,836,866
Prepaid expenses – related party (392,512) (1,728,666)
Prepaid expenses and other current assets 611,057 537,799
Prepaid taxes 3,686,137 1,161,649
Other noncurrent assets, net (696,951) (1,064,165)
Accounts payable (1,636,164) (110,912)
Accounts payable – related parties (1,640,793) 1,040,862
Accrued expenses and other liabilities 1,378,317 1,009,796
Loan and interest receivable – related party (992) (992)
Lease liabilities 108,659 (163,920)
Deferred revenue 1,732,492 7,075,046
Net cash provided by (used in) operating activities 6,862,539 (2,413,125)
Cash flows from investing activities:    
Acquisition of software (290,000)
Acquisition of software licenses (343,770) (2,008,690)
Investments in software (718,236)
Net cash paid for acquisition of Matrioshka (9,719)
Net cash used in investing activities (343,770) (3,026,645)
Cash flows from financing activities:    
Proceeds from at-the-market offering, net of issuance costs 4,232,897
Repayments on notes payable (594,376)
Repayments on convertible notes (2,523,295) (638,753)
Repayments on revolving loan (2,500,000) (43,018)
Borrowings on term loan 3,500,000
Cash proceeds from exercise of warrants 159,000
Proceeds from issuance of convertible notes 3,000,000
Payments of loan origination fees (7,500)
Net cash provided by (used in) financing activities (1,392,274) 5,977,229
Effect of foreign currency translation on cash and cash equivalents (25,839) 64,023
Net increase in cash and cash equivalents, and restricted cash and cash equivalents 5,100,656 601,482
Cash and cash equivalents, and restricted cash and cash equivalents – beginning of the period 10,503,164 8,238,944
Cash and cash equivalents, and restricted cash and cash equivalents – end of the period 15,603,820 8,840,426
Cash paid during the period for:    
Interest 311,933 230,318
Income taxes 82,428 612,007
Noncash transactions during the period for:    
Liabilities converted to equity upon exercise of warrants 606,541 323,113
Acquisition of film licenses in accounts payable 2,000 86,069
Acquisition of software and software licenses in accounts payable and accrued expenses 54,600 313,282
Change in fair value of notes recorded in accumulated other comprehensive income 5,310 22,023
Right-of-use assets obtained in exchange for lease liability (297,000) (55,267)
Net assets acquired in a business combination 5,461
Debt converted to equity 866,250
Nonrelated Party [Member]    
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization – intangible assets, net 327,756 79,424
Related Party [Member]    
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization – intangible assets, net $ 500,000